Involvement of PAR-4 in cannabinoid-dependent sensitization of osteosarcoma cells to TRAIL-induced apoptosis

Antonietta Notaro1, Selenia Sabella1, Ornella Pellerito2

  • 11. Laboratory of Biochemistry, Department of Biological, Chemical and Pharmaceutical Sciences and Technologies, University of Palermo, Polyclinic, Palermo, Italy.

Insights

The synthetic cannabinoid WIN 55,212-2 triggers cell cycle arrest and endoplasmic reticulum stress in osteosarcoma cells. While not inducing apoptosis directly, it primes cells for TRAIL-mediated death, suggesting anticancer potential.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Synthetic cannabinoids, like WIN 55,212-2, are potent cannabinoid receptor agonists.
  • These compounds exhibit potential anticancer properties warranting further investigation.
  • Osteosarcoma remains a challenging malignancy with a need for novel therapeutic strategies.

Purpose of the Study:

  • To investigate the effects of WIN 55,212-2 on human osteosarcoma cell lines (MG63 and Saos-2).
  • To determine the impact of WIN 55,212-2 on cell proliferation, cell cycle distribution, and programmed cell death.
  • To elucidate the underlying molecular mechanisms, including endoplasmic reticulum stress and autophagy.

Main Methods:

  • Treatment of MG63 and Saos-2 cells with WIN 55,212-2.
  • Analysis of cell cycle distribution using flow cytometry.
  • Assessment of endoplasmic reticulum stress markers (GRP78, CHOP, TRB3).
  • Evaluation of autophagy markers (LC3-I/II conversion, monodansylcadaverine, acridine orange staining).
  • Morphological analysis of treated cells.
  • Investigation of apoptotic pathways and the role of PAR-4 and TRAIL.

Main Results:

  • WIN 55,212-2 induced G2/M cell cycle arrest in osteosarcoma cells.
  • Treatment led to the upregulation of endoplasmic reticulum stress markers (GRP78, CHOP, TRB3).
  • Evidence of autophagy induction was observed, including LC3-II conversion and autolysosome formation.
  • Morphological changes included increased cell size and cytoplasmic vacuolization.
  • WIN 55,212-2 did not induce canonical apoptosis but increased PAR-4 levels and GRP78 cell surface translocation.
  • Co-treatment with TRAIL enhanced WIN 55,212-2-induced apoptotic death.

Conclusions:

  • WIN 55,212-2 exhibits anticancer effects in osteosarcoma cells by inducing cell cycle arrest, ER stress, and autophagy.
  • The compound modulates pathways that sensitize cells to TRAIL-induced apoptosis, suggesting a potential therapeutic role.
  • Further research into WIN 55,212-2 as a component of osteosarcoma treatment is warranted.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.7K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.6K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
1.1K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.2K